Myriad Genetics Inc.
MYGN | NASDAQ
$3.94
-$0.07 (-1.75%)
Sep 22, 2026, 1:05 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 190.7M | 200.4M | 209.8M | 205.7M | 213.1M | 195.9M | 210.6M | 213.3M | 211.5M | 202.2M | 196.6M | 191.9M | 183.5M | 181.2M | 177.8M | 156.4M | 179.3M | 164.9M | 160.8M | 167.3M | 189.4M | 173.1M |
Cost of Revenue | 63.7M | 62.8M | 63M | 61.9M | 61.3M | 61.7M | 59.7M | 63.5M | 64.4M | 64.6M | 61.6M | 57.6M | 57.8M | 59.2M | 53.9M | 50.4M | 49.7M | 48M | 45.8M | 47.8M | 53.7M | 50.3M |
Gross Profit | 127M | 137.6M | 146.8M | 143.8M | 151.8M | 134.2M | 150.9M | 149.8M | 147.1M | 137.6M | 135M | 134.3M | 125.7M | 122M | 123.9M | 106M | 129.6M | 116.9M | 115M | 119.5M | 135.7M | 122.8M |
Operating Income | -38.9M | -25.3M | -5.7M | -23.3M | -329.2M | -29M | -39M | -20M | -36.5M | -27.9M | -31.4M | -60.1M | -113.7M | -52.2M | -46M | -45M | -17.8M | -14.9M | -43.1M | -79.9M | -20.8M | -46.7M |
Interest Income | 400K | 700K | 800K | 500K | 200K | 300K | 300K | 400K | 400K | 600K | 700K | 600K | 500K | 700K | 1M | 1.1M | 400K | 100K | 100K | 200K | 200K | 200K |
Pretax Income | -42.6M | -34.1M | -8.9M | -26.2M | -330.6M | -29.4M | -39.1M | -21.2M | -37.2M | -25.9M | -32.3M | -61.2M | -116.1M | -52.6M | -52.1M | -44.2M | -17.9M | -26.4M | -43.5M | 39.8M | -3.8M | -49.6M |
Net Income | -43.2M | -34.1M | -7.9M | -27.4M | -330.5M | -100K | -42.5M | -22.1M | -36.7M | -26M | -31.2M | -61.3M | -116.1M | -54.7M | -42.3M | -35.1M | -14.1M | -20.5M | -7.6M | 24.6M | -4.7M | -39.5M |
Selling & General & Admin | 140.9M | 135.8M | 124.3M | 138.9M | 138.7M | 135.7M | 136M | 139.1M | 144.9M | 140.6M | 32.6M | 136.1M | 140.7M | 151.7M | 146.5M | 130.5M | 127.1M | 110.6M | 141.5M | 180.2M | 134.8M | 145.5M |
Research & Development | 25M | 27.1M | 25.5M | 28.2M | 25.6M | 27.5M | 32.2M | 28.5M | 27.1M | 24.9M | 21M | 24M | 21.2M | 22.5M | 23.4M | 20.5M | 20.3M | 21.2M | 16.6M | 18.8M | 19.5M | 23.1M |
Other Expenses | n/a | n/a | 2.7M | n/a | 316.7M | n/a | 21.7M | 2.2M | 11.6M | n/a | 112.8M | 34.3M | 77.5M | -600K | n/a | n/a | n/a | n/a | -100K | n/a | n/a | -100K |
Operating Expenses | 165.9M | 162.9M | 152.5M | 167.1M | 481M | 163.2M | 189.9M | 169.8M | 183.6M | 165.5M | 166.4M | 194.4M | 239.4M | 174.2M | 169.9M | 151M | 147.4M | 131.8M | 158.1M | 199M | 154.3M | 168.6M |
Interest Expense | -4.1M | 4.1M | 4.4M | 3.8M | 1.5M | 800K | 700K | 800K | 800K | 500K | 900K | 1M | 500K | 500K | 900K | 800K | 600K | 900K | 500K | 1.1M | 2M | 3M |
Selling & Marketing Expenses | 83.1M | 73.6M | 68.7M | 71M | 71.9M | 69.2M | 284.1M | n/a | 72.8M | 69.4M | n/a | n/a | -77.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 229.6M | 225.7M | 215.5M | 229M | 542.3M | 224.9M | 249.6M | 233.3M | 248M | 230.1M | 228M | 252M | 297.2M | 233.4M | 223.8M | 201.4M | 197.1M | 179.8M | 203.9M | 246.8M | 208M | 218.9M |
Income Tax Expense | 600K | n/a | -1M | 1.2M | -100K | -29.3M | 3.4M | 900K | -500K | 100K | -1.1M | 100K | n/a | 2.1M | -9.8M | -9.1M | -3.8M | -5.9M | -35.9M | 15.2M | 900K | -10.1M |
Shares Outstanding (Basic) | 94.8M | 93.7M | 93.3M | 93.1M | 92.5M | 91.4M | 91.1M | 90.9M | 90.6M | 89.9M | 86.1M | 81.73M | 81.7M | 81.3M | 81.5M | 80.7M | 78.33M | 78.85M | 76.14M | 78.8M | 77.2M | 75.96M |
Shares Outstanding (Diluted) | 94.8M | 93.7M | 93.3M | 93.1M | 92.5M | 91.4M | 91.1M | 90.9M | 90.6M | 89.9M | 86.1M | 81.9M | 81.7M | 81.3M | 81.5M | 80.7M | 80.4M | 80.1M | 79.9M | 81.5M | 77.2M | 76M |
EPS (Basic) | -0.46 | -0.36 | -0.08 | -0.29 | -3.57 | 0 | -0.47 | -0.24 | -0.41 | -0.29 | -0.36 | -0.75 | -1.42 | -0.67 | -0.52 | -0.43 | -0.18 | -0.26 | -0.10 | 0.31 | -0.06 | -0.52 |
EPS (Diluted) | -0.46 | -0.36 | -0.08 | -0.29 | -3.57 | 0 | -0.47 | -0.24 | -0.41 | -0.29 | -0.36 | -0.75 | -1.42 | -0.67 | -0.52 | -0.43 | -0.18 | -0.26 | -0.10 | 0.30 | -0.06 | -0.52 |
EBITDA | -38.9M | -17.5M | 8.1M | -9.8M | -315M | -14.2M | -23.6M | -4.8M | -21.3M | -9.7M | -16.3M | -46.1M | -102.3M | -32.7M | -31.3M | -30.3M | -4.4M | -1.8M | -29.7M | 55.5M | 17.3M | -27.3M |
EBIT | n/a | -30M | -4.5M | -22.4M | -329.1M | -28.6M | -38.4M | -20.4M | -36.4M | -25.4M | -31.4M | -60.2M | -115.6M | -52.2M | -46M | -43.4M | -17.3M | -14.9M | -43.1M | 40.9M | -1.8M | -46.6M |
Depreciation & Amortization | n/a | 12.5M | 12.6M | 12.6M | 14.1M | 14.4M | 14.8M | 15.6M | 15.1M | 15.7M | 15.1M | 14.1M | 13.3M | 19.5M | 14.7M | 13.1M | 12.9M | 13.1M | 13.3M | 14.2M | 16.9M | 18.4M |
Add to Watchlist
Select watchlists to add or remove MYGN